SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
EnVivo Pharmaceuticals, Inc. to Present Phase 2b Clinical Data of Lead Program in Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2012